Atovaquone-induced therapeutic rewiring of melanoma metabolism
Mayra A. Betancourt Ponce, Alexa R. Heaton, Samantha K. Burkard, Aurora D’Amato, Nicha Boonpattrawong, Melissa C. Skala, Manish S. Patankar, Lisa Marie Barroilhet
This study shows atovaquone inhibits OXPHOS and glycolysis in melanoma, causing metabolic reprogramming, oxidative stress, and reduced tumor growth in vitro and in vivo.
Journal of Investigative Dermatology · Mar 24, 2026Peer-reviewedCancer Biology